Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.51 USD | -0.94% | -5.46% | -4.94% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
Financials (USD)
Sales 2024 * | 600M | Sales 2025 * | 625M | Capitalization | 1.51B |
---|---|---|---|---|---|
Net income 2024 * | 14M | Net income 2025 * | -41M | EV / Sales 2024 * | 2.52 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.42 x |
P/E ratio 2024 * |
110
x | P/E ratio 2025 * |
-37.2
x | Employees | 652 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.98% |
Latest transcript on Supernus Pharmaceuticals, Inc.
1 day | -0.94% | ||
1 week | -5.46% | ||
Current month | -8.60% | ||
1 month | -8.51% | ||
3 months | -6.75% | ||
6 months | -1.15% | ||
Current year | -4.94% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Khattar
FOU | Founder | 62 | 05-03-29 |
Timothy Dec
DFI | Director of Finance/CFO | 66 | 21-08-22 |
Frank Mottola
CTO | Chief Tech/Sci/R&D Officer | 52 | 04-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Georges Gemayel
BRD | Director/Board Member | 64 | 15-03-22 |
Charles Newhall
CHM | Chairman | 79 | 05-03-29 |
John Siebert
BRD | Director/Board Member | 84 | 10-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.94% | 28 M€ | -1.64% | ||
0.94% | 14 M€ | -4.76% | ||
0.38% | 25 M€ | -2.72% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 27.51 | -0.94% | 453,220 |
24-05-23 | 27.77 | -0.36% | 623,542 |
24-05-22 | 27.87 | -0.64% | 966,793 |
24-05-21 | 28.05 | -2.50% | 706,784 |
24-05-20 | 28.77 | -1.13% | 712,784 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.94% | 1.51B | |
+16.59% | 79.16B | |
+8.99% | 8.72B | |
-16.83% | 4.79B | |
+47.36% | 4.62B | |
+1.74% | 3.82B | |
+14.51% | 2.33B | |
-26.23% | 2.2B | |
+15.63% | 2.1B | |
-34.87% | 2.04B |
- Stock Market
- Equities
- SUPN Stock